Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.29271/jcpsp.2020.supp2.S171 http://scihub22266oqcxt.onion/10.29271/jcpsp.2020.supp2.S171 33291198!ä!33291198 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Coll+Physicians+Surg+Pak 2020 ; 30 (10): 171-173 Nephropedia Template TP {{tp|p=33291198|t=2020. A Patient with COVID-19 Treated with ECMO for 26 Days |pdf=|usr=}}{{33291198}} gab.com Text A Patient with COVID-19 Treated with ECMO for 26 Days JO: J Coll Physicians Surg Pak http://www.kidney.de/pget.php?&tw=1&pmid=33291198 #FOAvip In December 2019, an outbreak of a novel coronavirus disease 2019 (COVID-19) was reported in Wuhan, China, which was subsequently reported in other countries worldwide. COVID-19 is typically an acute self-limited disease that can rarely be fatal with a 5.6% case mortality rate (May, 2020), mainly due to substantial damage to pulmonary alveolar structures, and subsequent respiratory failure. Given the previous experience, extracorporeal membrane oxygenation (ECMO) has been proven to be an effective therapy in the treatment of respiratory failure or acute respiratory distress syndrome (ARDS). On the basis of similar principle, ECMO may also be an effective therapy in the treatment of severe COVID-19. However, due to huge cost, it is not common to apply ECMO continuously for a long time. We, herein, describe a COVID-19 pneumonia patient, a 77-year female?who was treated with ECMO for 26 days. The hospitalisation costs of the patient were highest in Jilin Province. Key Words: COVID-19, ECMO, Pneumonia. Twit Text FOAVip A Patient with COVID-19 Treated with ECMO for 26 Days ????J Coll Physicians Surg Pak http://www.kidney.de/pget.php?&tw=1&pmid=33291198 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33291198 #FOAvip English Wikipedia <ref>{{Cite pmid|33291198}}</ref> A Patient with COVID-19 Treated with ECMO for 26 Days #MMPMID33291198 Zhang C; Shi B; Ma H; Dong N J Coll Physicians Surg Pak 2020[Oct]; 30 (10): 171-173 PMID33291198show ga In December 2019, an outbreak of a novel coronavirus disease 2019 (COVID-19) was reported in Wuhan, China, which was subsequently reported in other countries worldwide. COVID-19 is typically an acute self-limited disease that can rarely be fatal with a 5.6% case mortality rate (May, 2020), mainly due to substantial damage to pulmonary alveolar structures, and subsequent respiratory failure. Given the previous experience, extracorporeal membrane oxygenation (ECMO) has been proven to be an effective therapy in the treatment of respiratory failure or acute respiratory distress syndrome (ARDS). On the basis of similar principle, ECMO may also be an effective therapy in the treatment of severe COVID-19. However, due to huge cost, it is not common to apply ECMO continuously for a long time. We, herein, describe a COVID-19 pneumonia patient, a 77-year female?who was treated with ECMO for 26 days. The hospitalisation costs of the patient were highest in Jilin Province. Key Words: COVID-19, ECMO, Pneumonia. |*SARS-CoV-2[MESH] |Aged[MESH] |COVID-19/complications/epidemiology/*therapy[MESH] |Extracorporeal Membrane Oxygenation/*methods[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Humans[MESH] |Respiratory Insufficiency/etiology/*therapy[MESH]A Patient with COVID-19 Treated with ECMO for 26 Days (epmc).pdf DeepDyve Pubget Overpricing